Literature DB >> 2342544

Neuropsychiatric side effects of mefloquine.

D Stürchler, J Handschin, D Kaiser, L Kerr, M L Mittelholzer, R Reber, M Fernex.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2342544     DOI： 10.1056/nejm199006143222416

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Bipolar disorder after mefloquine treatment.

Authors:  C Even; S Friedman; K Lanouar
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

2.  Clearing the air on malaria.

Authors:  R Wittes
Journal:  CMAJ       Date:  1991-03-15       Impact factor: 8.262

3.  Associations between Use of Antimalarial Medications and Health among U.S. Veterans of the Wars in Iraq and Afghanistan.

Authors:  Aaron I Schneiderman; Yasmin S Cypel; Erin K Dursa; Robert M Bossarte
Journal:  Am J Trop Med Hyg       Date:  2018-06-21       Impact factor: 2.345

4.  Implications of Changes to the Mefloquine Product Monograph.

Authors:  Remington L Nevin
Journal:  Can J Hosp Pharm       Date:  2017-08-31

5.  Investigation of the in vitro gender-specific partitioning of mefloquine in malarial infected red blood cells and plasma.

Authors:  Nongluk Seethorn; Walther H Wernsdorfer; Harald Noedl; Juntra Karbwang; Kesara Na-Bangchang
Journal:  Am J Trop Med Hyg       Date:  2013-09-03       Impact factor: 2.345

Review 6.  Adverse effects of antimalarials. An update.

Authors:  G A Luzzi; T E Peto
Journal:  Drug Saf       Date:  1993-04       Impact factor: 5.606

7.  Adverse reaction to mefloquine associated with ethanol ingestion.

Authors:  R C Wittes; R Saginur
Journal:  CMAJ       Date:  1995-02-15       Impact factor: 8.262

8.  Low body mass index is associated with an increased risk of neuropsychiatric adverse events and concentration impairment in women on mefloquine.

Authors:  M M van Riemsdijk; M C J M Sturkenboom; J M Ditters; J H M Tulen; R J Ligthelm; D Overbosch; B H Stricker
Journal:  Br J Clin Pharmacol       Date:  2004-04       Impact factor: 4.335

9.  Neuropsychiatric Adverse Reactions to Mefloquine: a Systematic Comparison of Prescribing and Patient Safety Guidance in the US, UK, Ireland, Australia, New Zealand, and Canada.

Authors:  Remington L Nevin; Aricia M Byrd
Journal:  Neurol Ther       Date:  2016-05-30

Review 10.  Rational Risk-Benefit Decision-Making in the Setting of Military Mefloquine Policy.

Authors:  Remington L Nevin
Journal:  J Parasitol Res       Date:  2015-10-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.